Sreekumar, S.; Zhou, D.; Mpoy, C.; Schenk, E.; Scott, J.; Arbeit, J.M.; Xu, J.; Rogers, B.E.
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. Int. J. Mol. Sci. 2023, 24, 3083.
https://doi.org/10.3390/ijms24043083
AMA Style
Sreekumar S, Zhou D, Mpoy C, Schenk E, Scott J, Arbeit JM, Xu J, Rogers BE.
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. International Journal of Molecular Sciences. 2023; 24(4):3083.
https://doi.org/10.3390/ijms24043083
Chicago/Turabian Style
Sreekumar, Sreeja, Dong Zhou, Cedric Mpoy, Elsa Schenk, Jalen Scott, Jeffrey M. Arbeit, Jinbin Xu, and Buck E. Rogers.
2023. "Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer" International Journal of Molecular Sciences 24, no. 4: 3083.
https://doi.org/10.3390/ijms24043083
APA Style
Sreekumar, S., Zhou, D., Mpoy, C., Schenk, E., Scott, J., Arbeit, J. M., Xu, J., & Rogers, B. E.
(2023). Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. International Journal of Molecular Sciences, 24(4), 3083.
https://doi.org/10.3390/ijms24043083